Consent for Participation in a Research Study

Protocol Title: National Practice Patterns in Treatment and Surveillance of Male Breast Cancer: A Survey Study

Principle Investigator: Jennifer Q. Zhang, MD 

You are invited to participate in this online survey. This data will be used to explore current breast cancer practices in male breast cancer (MBC). MBC is extremely rare and makes up only 1% of all breast malignancies. Management of MBC is extrapolated from current treatment guidelines on female breast cancer (FBC). However, studies have suggested that MBC has a different tumor biology and presentation than FBC, suggesting that MBC should be considered a distinct disease. The purpose of this survey is to identify trends in current practices and views by surgeons on treatment of MBC. 

Participation in this study is completely voluntary. If you prefer not to participate, do not complete this survey. There is no penalty if you choose not to complete this survey, and you may exit at any time. This survey will take about 5-10 minutes to complete. 

All responses are completely anonymous. A few questions will be asked on demographics and career practice. However, no identifiable information will be requested in this survey. Investigators will not have access to other identifiers, such as name, email addresses, and IP addresses. Data will be stored in a de-identified fashion. Only members of the research team will have access to this data for the purposes of conducting the study. This information will be used for publication; however, your participation will not be identified in this study. 

If you have any questions and/or concerns with this study, please email Jasmine Phun at phunj@pennmedicine.upenn.eduand/or the PI Dr. Jennifer Zhang at jennifer.zhang@pennmedicine.upenn.edu. This study has been reviewed by the Institutional Review Board at the University of Pennsylvania. For any questions regarding your rights as a human research participant, please contact the University of Pennsylvania Institutional Review Board (IRB) at 215-898-2614 for assistance. Thank you for taking the time to complete this survey! 

Sign in to Google to save your progress. Learn more
What is your age? *
What is your gender? *
What is your practice setting? (check all that apply) *
Required
How large is the population of the city in which you practice? *
Where do you practice? *
How many years have you been in practice? *
What is your specialty? *
What percentage of your practice is devoted to the care of breast cancer patients? *
Perspectives on MBC *
Strongly Disagree
Somewhat Disagree
Neither Agree or Disagree
Somewhat Agree
Strongly Agree
Male breast cancer (MBC) should be treated similarly to female breast cancer (FBC).
MBC has a similar mortality to FBC.
Aromatase inhibitors are just as effective as Tamoxifen in treating hormone receptor-positive MBC.
Treatment of MBC *
Never
Rarely
Sometimes
Often
Always
I offer breast conservation therapy (BCT) over total mastectomy to MBC patients if they meet criteria.
I discuss the nipple-sparing technique as an option for MBC patients who plan to undergo complete mastectomy.
I refer MBC patients to a plastic surgeon for postmastectomy reconstruction and/or tissue rearrangement.
I offer contralateral prophylactic mastectomy to MBC patients who are BRCA1/2-positive.
I feel comfortable omitting sentinel lymph node biopsy in MBC patients who meet SOUND trial criteria.
I order Oncotype DX testing for all MBC patients who fit criteria and are NODE NEGATIVE on pathology.
I order Oncotype DX testing for all MBC patients who fit criteria and have 1-3 POSITIVE NODES on pathology.
For MBC patients who undergo BCT *
Never
Rarely
Sometimes
Often
Always
I offer annual IPSILATERAL mammography to MBC patients with POSITIVE genetic testing.
I offer annual IPSILATERAL mammography to MBC patients with NEGATIVE genetic testing.
I offer annual BILATERAL mammography to MBC patients with POSITIVE genetic testing.
I offer annual BILATERAL mammography to MBC patients with NEGATIVE genetic testing.
For MBC patients who undergo mastectomy *
Never
Rarely
Sometimes
Often
Always
I offer annual CONTRALATERAL mammography to MBC patients with POSITIVE genetic testing
I offer annual CONTRALATERAL mammography to MBC patients with NEGATIVE genetic testing.
Genetics *
Never
Rarely
Sometimes
Often
Always
I recommend genetic testing to male patients diagnosed with breast cancer.

Choose one of the following if you recommend genetic testing to MBC patients:

*
Next
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report